Global Biosimilar Monoclonal Antibodies (mAbs) Market in Pharmaceuticals Industry|Discover Company Insights in Technavio

NEW YORK, July 23, 2021 /PRNewswire/ -- The biosimilar monoclonal antibodies (mAbs) market is poised to grow by USD 3.48 billion during 2021-2025, progressing at a CAGR of 14.05% during the forecast period.

Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Download FREE Sample Report

The report on the biosimilar monoclonal antibodies (mAbs) market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by factors such as the increasing prevalence of chronic diseases, the increase in the number of expiring patents of blockbuster mAbs, and the growing approval for biosimilar mAbs.

The biosimilar monoclonal antibodies (mAbs) market analysis includes application and geography landscape segments. This study identifies the growing approval for biosimilar mAbs as one of the prime reasons driving the biosimilar monoclonal antibodies (mAbs) market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The biosimilar monoclonal antibodies (mAbs) the market covers the following areas:

Biosimilar Monoclonal Antibodies (mAbs) Market Sizing
Biosimilar Monoclonal Antibodies (mAbs) Market Forecast
Biosimilar Monoclonal Antibodies (mAbs) Market Analysis

Companies Mentioned

• Amgen Inc.
• BIOCAD
• Biocon Ltd.
• BioXpress Therapeutics SA
• Boehringer Ingelheim International GmbH
• Celltrion Co. Ltd.
• Coherus Biosciences Inc.
• Intas Pharmaceuticals Ltd.
• Novartis AG
• Pfizer Inc.

Related Reports on Health Care Include:

Global Drug Discovery Outsourcing Market- The drug discovery outsourcing market is segmented by product (small molecules and biologics) and geography (North America, Europe, Asia, and ROW).
Download FREE Sample Report

Global Chemotherapy-induced Nausea and Vomiting Drugs Market- Chemotherapy-induced nausea and vomiting drugs market is segmented by therapy (serotonin receptor antagonists, NK1 receptor antagonists, and others) and geography (North America, Europe, Asia, and ROW).
Download FREE Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Application

• Market segments
• Comparison by Application
• Cancer - Market size and forecast 2020-2025
• Non-cancer - Market size and forecast 2020-2025
• Market opportunity by Application

Customer landscape

• Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Amgen Inc.
• BIOCAD
• Biocon Ltd.
• BioXpress Therapeutics SA
• Boehringer Ingelheim International GmbH
• Celltrion Co. Ltd.
• Coherus Biosciences Inc.
• Intas Pharmaceuticals Ltd.
• Novartis AG
• Pfizer Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Report link: https://www.technavio.com/report/biosimilar-monoclonal-antibodies-market-industry-analysis

SOURCE Technavio